Telesis Bio

📍 San Diego, United States🗓 Founded 2013👥 116 employees💰 Last funded Aug 2019
Biotechnology🌐 telesisbio.com
Website LinkedIn
Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges. With our breakthrough automation solutions for biological synthesis and expertise in DNA biology, we enable rapid, accurate, and reproducible writing of DNA and mRNA for wide-ranging biological applications. Around the world, innovators are leveraging Telesis Bios technology to overcome current bottlenecks in synthetic biology workflows and advance the discovery of cutting-edge solutions for health and technology. We are proud of our growing collaborations with partners that include premier academic research institutions, emerging start-ups to nearly all of the Top 25 Biopharma companies. Telesis Bio is honored to play a part in several pioneering advances of our customers and collaborators ranging from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Telesis Bio?
Telesis Bio has 1 investors on record on gritt.io and 1 late-stage investors.
When did Telesis Bio last raise funding?
The most recent investment in Telesis Bio recorded on gritt.io was in August 2019.
When was Telesis Bio founded?
Telesis Bio was founded in 2013.
What industry is Telesis Bio in?
Telesis Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Telesis Bio based?
Telesis Bio is headquartered in San Diego, United States.